Identification of ischemia-regulated phosphorylation sites in connexin43: A possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123)

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 6, 2006, Pages 790-798

  Axelsen, Lene N ^a   Stahlhut, Martin ^a   Mohammed, Shabaz ^b   Larsen, Bjarne Due ^a   Nielsen, Morten S ^c   Holstein Rathlou, Niels Henrik ^c   Andersen, Søren ^b   Jensen, Ole N ^b   Hennan, James K ^d   Kjølbye, Anne Louise ^a  

^a Zealand Pharma AS   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d PFIZER INC   (United States)

Author keywords

Arrhythmias; Connexin43; Gap junction; Ischemia; Phosphorylation; Rotigaptide

Indexed keywords

ANTIARRHYTHMIC AGENT; CONNEXIN 43; ROTIGAPTIDE; SERINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYSTOLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; ELECTROSPRAY MASS SPECTROMETRY; GAP JUNCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; ISOLATED HEART; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; RAT; REGULATORY MECHANISM; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANIMALS; CONNEXIN 43; HEART ARREST; MALE; MOLECULAR SEQUENCE DATA; MYOCARDIAL ISCHEMIA; OLIGOPEPTIDES; PHOSPHORYLATION; PHOSPHOTRANSFERASES; RATS; RATS, SPRAGUE-DAWLEY; SERINE;

EID: 33744521144     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.03.005     Document Type: Article

References (32)

1. van Veen T.A.B., van Rijen H.V., and Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc. Res. 51 (2001) 217-229
2. Gutstein D.E., Morley G.E., Tamaddon H., Vaidya D., Schneider M.D., Chen J., et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ. Res. 88 (2001) 333-339
3. Kléber A.G. Mechanisms of ventricular arrhythmias: a perspective. J. Cardiovasc. Pharmacol. 17 (1991) S1-S8
4. Peters N.S., Coromilas J., Severs N.J., and Wit A.L. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95 (1997) 988-996
5. Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol. Sci. 19 (1998) 229-241
6. Beardslee M.A., Lerner D.L., Tadros P.N., Laing J.G., Beyer E.C., Yamada K.A., et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ. Res. 87 (2000) 656-662
7. Bao X., Reuss L., and Altenberg G.A. Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of serine 368. J. Biol. Chem. 279 (2004) 20058-20066
8. Cameron S.J., Malik S., Akaike M., Lerner-Marmarosh N., Yan C., Lee J.D., et al. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase 1/ERK5 but not ERK1/2 kinase activation. J. Biol. Chem. 278 (2003) 18682-18688
9. Cooper C.D., and Lampe P.D. Casein kinase 1 regulates connexin-43 gap junction assembly. J. Biol. Chem. 277 (2002) 44962-44968
10. Doble B.W., Dang X., Ping P., Fandrich R.R., Nickel B.E., Jin Y., et al. Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J. Cell Sci. 117 (2004) 507-514
11. Kwak B.R., Saez J.C., Wilders R., Chanson M., Fishman G.I., Hertzberg E.L., et al. Effects of cGMP-dependent phosphorylation on rat and human connexin43 gap junction channels. Eur. J. Physiol. 430 (1995) 770-778
12. Kwak B.R., and Jongsma H.J. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell. Biochem. 157 (1996) 93-99
13. Lampe P.D., TenBroek E.M., Burt J.M., Kurata W.E., and Johnson R.G. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J. Cell Biol. 149 (2000) 1503-1512
14. Lin R., Warn-Cramer B.J., Kurata W.E., and Lau A.F. v-Src phosphorylation of connexin 43 on Tyr247 and Tyr265 disrupts gap junctional communication. J. Cell Biol. 154 (2001) 815-828
15. Shah M.M., Martinez A.M., and Fletcher W.H. The connexin43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: in vivo and in vitro studies. Mol. Cell. Biochem. 238 (2002) 57-68
16. TenBroek E.M., Lampe P.D., Solan J.L., Reynhout J.K., and Johnson R.G. Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J. Cell Biol. 155 (2001) 1307-1318
17. Toyofuku T., Akamatsu Y., Zhang H., Kuzuya T., Tada M., and Hori M. c-Src regulates the interaction between connexin-43 and ZO-1 in cardiac myocytes. J. Biol. Chem. 276 (2001) 1780-1788
18. Warn-Cramer B.J., Lampe P.D., Kurata W.E., Kanemitsu M.Y., Loo L.W.M., Eckhart W., et al. Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin-43 gap junction protein. J. Biol. Chem. 271 (1995) 3779-3786
19. Eloff B.C., Gilat E., Wan X., and Rosenbaum D.S. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction. Evidence supporting a novel target for antiarrhythmic therapy. Circulation 108 (2003) 3157-3163
20. Kjølbye A.L., Knudsen C.B., Jepsen T., Larsen B.D., and Petersen J.S. Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J. Pharmacol. Exp. Ther. 306 (2003) 1191-1199
21. Xing D., Kjølbye A.L., Nielsen M.S., Petersen J.S., Harlow K.W., Holstein-Rathlou N.H., et al. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J. Cardiovasc. Electrophysiol. 14 (2003) 510-520
22. Dupont E., El Aoumari A., Fromaget C., Briand J.P., and Gros D. Affinity purification of rat-brain junctional protein, connexin43. Eur. J. Biochem. 200 (1991) 263-270
23. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
24. Gobom J., Nordhoff E., Mirgorodskaya E., Ekman R., and Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34 (1999) 105-116
25. Stensballe A., Andersen S., and Jensen O.N. Characterization of phosphoproteins from electrophoretic gels by nanoscale Fe(III) affinity chromatography with off-line mass spectrometry analysis. Proteomics 1 (2001) 207-222
26. Perkins D.N., Pappin D.J.C., Creasy D.M., and Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 (1999) 3551-3567
27. Weng S., Lauven M., Schaefer T., Polontchouk L., Grover R., and Dhein S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J. 16 (2002) 1114-1116
28. Kleber A.G., Riegger C.B., and Janse M.J. Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ. Res. 61 (1987) 271-279
29. Jain S.K., Schuessler R.B., and Saffitz J.E. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ. Res. 92 (2003) 1138-1144
30. Eloff B.C., Gilat E., Wan X., and Rosenbaum D.S. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction. Evidence supporting a novel target for antiarrhythmic therapy. Circulation 108 (2003) 3157-3163
31. Xing D., Kjolbye A.L., Petersen J.S., and Martins J.B. Pharmacological stimulation of cardiac gap junction coupling does not affect ischemia-induced focal ventricular tachycardia or triggered activity in dogs. Am. J. Physiol.: Heart Circ. Physiol. 288 (2005) H511-H516
32. Boengler K., Dodoni G., Rodriguez-Sinovas A., Cabestrero A., Ruiz-Meana M., Gres P., et al. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc. Res. 62 (2005) 234-244